{"id":333479,"date":"2017-02-16T10:42:19","date_gmt":"2017-02-16T02:42:19","guid":{"rendered":"http:\/\/techcrunch.com\/?p=1453535"},"modified":"2017-02-16T10:42:19","modified_gmt":"2017-02-16T02:42:19","slug":"crispr-cas9-inventor-jennifer-doudnas-plans-on-moving-forward-genetically-modifying-humans","status":"publish","type":"post","link":"https:\/\/people.utm.my\/asmawisham\/crispr-cas9-inventor-jennifer-doudnas-plans-on-moving-forward-genetically-modifying-humans\/","title":{"rendered":"CRISPR-Cas9 inventor Jennifer Doudna\u2019s plans on moving forward, genetically modifying humans"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=738\" class=\"\"\/><\/p>\n<p>The decision of who owned the rights to a <a target=\"_blank\" href=\"https:\/\/techcrunch.com\/2016\/11\/07\/the-legal-argument-for-who-owns-crispr-cas9-starts-next-month\/\">hotly disputed<\/a> CRISPR gene editing patent came down in favor of the Broad Institute of MIT and Harvard today so you\u2019d think the mood would be sour at the University of California, Berkeley, the other contender in the case. But Berkeley\u2019s Jennifer Doudna tells TechCrunch this is a positive for her.<\/p>\n<p>\u201cI\u2019m actually delighted to know the claims of our original patent have been allowed by the patent examiner and can now move forward towards issuance,\u201d she said.<\/p>\n<p> Doudna is credited with being the first to figure out how to use CRISPR to program cells using the Cas9 enzyme. UC Berkeley filed a\u00a0patent on behalf of Doudna\u2019s work but the Broad Institute used a fast-track option to beat UC Berkeley to the punch when it came to a patent for the same technique on the more complex eukaryotic cells \u2014 a nuanced difference that Doudna and her co-inventor Emmanuelle Charpentier claimed was an \u201cobvious\u201d next step in the process and should not be considered for a separate patent.<\/p>\n<p>While much of the science world seemed to agree with Doudna and her cohorts, the U.S. patent office thought the Broad Institute deserved a separate patent for making that leap.<\/p>\n<p>But, as Doudna points out that, though the judge did not\u00a0throw out the Broad Institute\u2019s claims to that patent, it also doesn\u2019t throw out her claim that her patent should be able to cover all cells. \u201cWe\u2019re actually anticipating getting our patent issued finally, one that has very broad claims,\u201d she says, comparing the two patents to tennis balls.<\/p>\n<p>\u201cThe analogy I\u2019ve used to explain this is the Broad Institute\u2019s patent is for green tennis balls but the patent we will have is for all tennis balls,\u201d Doudna told TechCrunch.<\/p>\n<p>What the decision doesn\u2019t make clear is who companies should now license from. Companies such as Monsanto, GE Healthcare and others working with the Broad Institue or Doudna\u2019s CRISPR startup Caribou Bioscience may have to get licenses from both parties if they want to work on CRISPRing plants and animal cells for research.<\/p>\n<p>\u201cThis will be an on-going thing and most likely additional filings,\u201d says Doudna, who also did not rule out the potential Berkeley could appeal the decision.<\/p>\n<p>Meanwhile, Berkeley has formed a partnership with the University of California San Francisco to form the I<a target=\"_blank\" href=\"https:\/\/innovativegenomics.org\/\">nnovative Genomics Institute<\/a>\u00a0(IGI), which will be working with Doudna\u2019s technology to research solving human genetic diseases and is also looking at solving issues in plant genomics.<\/p>\n<p>But the important piece for Doudna is that everyone can at least start to move forward in applying the technology. \u201cIn the end, as scientists, we would all like to see this technology help people and ultimately that\u2019s got to be the goal that we all have,\u201d she\u00a0tells TechCrunch.<\/p>\n<p>The decision may come at just the right time as the use of CRISPR in modifying human embryos with certain heritable diseases was <a target=\"_blank\" href=\"https:\/\/www.nytimes.com\/2017\/02\/14\/health\/human-gene-editing-panel.html?_r=0\">just approved<\/a> by a science advisory panel\u00a0formed by the National Academy of Sciences and the National Academy of Medicine this week.<\/p>\n<p><small>Featured Image: Jennifer Doudna\/Getty Images<\/small><\/p>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"680\" height=\"453\" src=\"https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=680\" class=\"attachment-large size-large wp-post-image\" alt=\"PARIS, FRANCE - MARCH 24: Laureate Professor Jennifer Doudna (for reinventing genetic research - she&#039;s from USA) attends the &quot;L&#039;Oreal-UNESCO Awards 2016 For Women in Science International&quot;, hosted by Fondation l&#039;Oreal at Maison de la Mutualite on March 24, 2016 in Paris, France. (Photo by Bertrand Rindoff Petroff\/Getty Images for Fondation L&#039;oreal)\" srcset=\"https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=680 680w, https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=1360 1360w, https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=150 150w, https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=300 300w, https:\/\/tctechcrunch2011.files.wordpress.com\/2016\/07\/gettyimages-517322026.jpg?w=768 768w\" sizes=\"(max-width: 680px) 100vw, 680px\" \/>&nbsp;The decision of who owned the rights to a hotly disputed CRISPR gene editing patent came down in favor of the Broad Institute of MIT and Harvard today so you&#8217;d think the mood would be sour at the University of California, Berkeley, the other contender in the case. But Berkeley&#8217;s Jennifer Doudna tells TechCrunch this is a positive for her. &#8220;I&#8217;m actually delighted to know&hellip; <a href=\"https:\/\/techcrunch.com\/2017\/02\/15\/crispr-cas9-inventor-jennifer-doudnas-plans-on-moving-forward-genetically-modifying-humans\/?ncid=rss\">Read More<\/a><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=ALvJsBk_6LM:XlvOfcKAJX0:2mJPEYqXBVI\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=2mJPEYqXBVI\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=ALvJsBk_6LM:XlvOfcKAJX0:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=7Q72WNTAKBA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=ALvJsBk_6LM:XlvOfcKAJX0:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=ALvJsBk_6LM:XlvOfcKAJX0:-BTjWOF_DHI\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?i=ALvJsBk_6LM:XlvOfcKAJX0:-BTjWOF_DHI\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=ALvJsBk_6LM:XlvOfcKAJX0:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?i=ALvJsBk_6LM:XlvOfcKAJX0:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?a=ALvJsBk_6LM:XlvOfcKAJX0:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/Techcrunch?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Techcrunch\/~4\/ALvJsBk_6LM\" height=\"1\" width=\"1\" alt=\"\"\/> <\/p>\n","protected":false},"author":5817,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[25],"tags":[59,66,26],"class_list":["post-333479","post","type-post","status-publish","format-standard","hentry","category-technology","tag-media","tag-techcrunch","tag-technology"],"_links":{"self":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts\/333479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/users\/5817"}],"replies":[{"embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/comments?post=333479"}],"version-history":[{"count":0,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/posts\/333479\/revisions"}],"wp:attachment":[{"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/media?parent=333479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/categories?post=333479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/people.utm.my\/asmawisham\/wp-json\/wp\/v2\/tags?post=333479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}